Cargando…

Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology

OBJECTIVES: Hypophosphatasia (HPP) is a rare genetic metabolic bone disease that can cause chronic pain and fractures. Its hallmark is a persistently low serum ALP. HPP is now recognised by many osteoporosis specialists, but other specialists, such as rheumatologists and primary care physicians, may...

Descripción completa

Detalles Bibliográficos
Autores principales: Rauf, Muhammad A., Kotecha, Jalpa, Moss, Katie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427523/
https://www.ncbi.nlm.nih.gov/pubmed/37118032
http://dx.doi.org/10.1007/s00198-023-06749-z
_version_ 1785090261568716800
author Rauf, Muhammad A.
Kotecha, Jalpa
Moss, Katie
author_facet Rauf, Muhammad A.
Kotecha, Jalpa
Moss, Katie
author_sort Rauf, Muhammad A.
collection PubMed
description OBJECTIVES: Hypophosphatasia (HPP) is a rare genetic metabolic bone disease that can cause chronic pain and fractures. Its hallmark is a persistently low serum ALP. HPP is now recognised by many osteoporosis specialists, but other specialists, such as rheumatologists and primary care physicians, may be less aware of this condition, causing diagnostic delay and possible harm to these patients. Our objective was to highlight features that can reduce this delay. METHODS: We retrospectively analysed 14 patients that presented with musculoskeletal pain to general rheumatology clinic at St. George’s Hospital and were subsequently diagnosed with HPP. RESULTS: Median diagnostic delay was 13 years. All patients had an ALP below reference range for age and gender, with lowest mean ALP of 16 IU/L. All but one patient were women with median age of 51 years. Most common presentation was peripheral joint pain in 85.7% of patients. This was due to early-onset CPPD (calcium pyrophosphate deposition disease) in 71.4% of patients, osteoarthritis in 50%, or bursitis in 50%. Axial pain was reported in 64% of patients due to osteoarthritis or spinal stenosis. Fifty percent of patients had a history of long bone pain. Fifty percent had previous fracture(s). A total of 28.6% of patients had psoriatic arthritis, of which 1 patient had spondyloarthropathy, and 4 patients also had enthesitis. CONCLUSION: Patients with HPP can present to rheumatology with musculoskeletal pain, and if a persistently low ALP is confirmed, this may reduce the diagnostic delay of this rare disease. Similar to other rheumatologic patients, musculoskeletal pain in HPP was noted in peripheral joints and in the spine with almost a third of patients having psoriatic arthritis. Pain was also noted in the long bones, a feature consistent with metabolic bone disease. The diagnosis of HPP was also more likely in those patients with a personal or family history of dental disease or arthritis.
format Online
Article
Text
id pubmed-10427523
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-104275232023-08-17 Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology Rauf, Muhammad A. Kotecha, Jalpa Moss, Katie Osteoporos Int Short Communication OBJECTIVES: Hypophosphatasia (HPP) is a rare genetic metabolic bone disease that can cause chronic pain and fractures. Its hallmark is a persistently low serum ALP. HPP is now recognised by many osteoporosis specialists, but other specialists, such as rheumatologists and primary care physicians, may be less aware of this condition, causing diagnostic delay and possible harm to these patients. Our objective was to highlight features that can reduce this delay. METHODS: We retrospectively analysed 14 patients that presented with musculoskeletal pain to general rheumatology clinic at St. George’s Hospital and were subsequently diagnosed with HPP. RESULTS: Median diagnostic delay was 13 years. All patients had an ALP below reference range for age and gender, with lowest mean ALP of 16 IU/L. All but one patient were women with median age of 51 years. Most common presentation was peripheral joint pain in 85.7% of patients. This was due to early-onset CPPD (calcium pyrophosphate deposition disease) in 71.4% of patients, osteoarthritis in 50%, or bursitis in 50%. Axial pain was reported in 64% of patients due to osteoarthritis or spinal stenosis. Fifty percent of patients had a history of long bone pain. Fifty percent had previous fracture(s). A total of 28.6% of patients had psoriatic arthritis, of which 1 patient had spondyloarthropathy, and 4 patients also had enthesitis. CONCLUSION: Patients with HPP can present to rheumatology with musculoskeletal pain, and if a persistently low ALP is confirmed, this may reduce the diagnostic delay of this rare disease. Similar to other rheumatologic patients, musculoskeletal pain in HPP was noted in peripheral joints and in the spine with almost a third of patients having psoriatic arthritis. Pain was also noted in the long bones, a feature consistent with metabolic bone disease. The diagnosis of HPP was also more likely in those patients with a personal or family history of dental disease or arthritis. Springer London 2023-04-28 2023 /pmc/articles/PMC10427523/ /pubmed/37118032 http://dx.doi.org/10.1007/s00198-023-06749-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Short Communication
Rauf, Muhammad A.
Kotecha, Jalpa
Moss, Katie
Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology
title Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology
title_full Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology
title_fullStr Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology
title_full_unstemmed Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology
title_short Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology
title_sort reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427523/
https://www.ncbi.nlm.nih.gov/pubmed/37118032
http://dx.doi.org/10.1007/s00198-023-06749-z
work_keys_str_mv AT raufmuhammada reducingdiagnosticdelayinhypophosphatasiaacaseseriesof14patientspresentingtogeneralrheumatology
AT kotechajalpa reducingdiagnosticdelayinhypophosphatasiaacaseseriesof14patientspresentingtogeneralrheumatology
AT mosskatie reducingdiagnosticdelayinhypophosphatasiaacaseseriesof14patientspresentingtogeneralrheumatology